Skip to main content

Cycurion, Inc.

For the period ended Sep 30, 2025. Filed Nov 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 14, 2025

CYCU$2.470.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 2. Results of Operations

Results of Operations

Table MD&A 1: Consolidated Results of Operations
For the Three Months EndedFor the Nine Months Ended
September 30, 2025September 30, 2024September 30, 2025September 30, 2024
Net revenues$3,833,038$4,450,447$11,591,003$13,694,614
Cost of revenues3,562,5593,732,43110,406,82411,605,722
Gross profit270,479718,0161,184,1792,088,892
Gross profit percentage7.1%16.1%10.2%15.3%
Operating expenses:
Selling, general and administrative expenses2,719,600299,2335,244,323963,000
Stock compensation expenses2,082,000—3,094,44310,000
Business combination expenses——11,240,114—
Total operating expenses4,801,600299,23319,578,880973,000
Operating (loss)/income(4,531,121)418,783(18,394,701)1,115,892
Interest income1,770—1,77020,211
Interest expense(712,374)(319,666)(1,506,657)(1,033,496)
Gain on debt settlement, net2,016,469—1,250,139—
Other (expense)/income(14,761)16,976(129,468)7,105
Other expense/(income), net1,291,104(302,690)(384,216)(1,006,180)
(Loss)/income before income taxes(3,240,017)116,093(18,778,917)109,712
Provision for income tax————
Net (loss)/income(3,240,017)116,093(18,778,917)109,712
Less: Net loss attributable to non-controlling interest116,700—218,359—
Net (loss)/income attributable to Cycurion$(3,123,317)$116,093$(18,560,558)$109,712

Revenue

Revenues for the three months ended September 30, 2025 decreased $0.6 million or 13.9% compared to the three months ended September 30, 2024. For the nine months ended September 30, 2025, revenues decreased by $2.1 million or 15.4% compared to same period in 2024.

We attribute this decrease in the revenues in 2025 compared to 2024 to delayed start dates of new federal, state and local contracts and the company’s focus on more profitable business.

Cost of Revenue

The cost of revenue for the three and nine months ended September 30, 2025, was approximately $3.6 million and $10.4 million, respectively, compared to $3.7 million and $11.6 million for the same periods in 2024, respectively. The cost of revenue is driven by the costs incurred while delivering services to our customers.

Selling, general and administrative (“SG&A”) expenses

Our selling, general and administrative (“SG&A”) expenses increased in 2025 compared to 2024 due to additional expenses being recognized in 2025 due to increased costs associated with being a publicly traded company and the addition key individuals for the company's growth strategy.

Stock compensation expenses

Stock compensation expenses increased in 2025 compared to 2024 as a result of new compensation agreements with executives.

Business combination expenses

Business combination expenses in 2025 are a result of the business combination with Western in Q1 2025.

Interest income

Interest income for both the three and nine months ended September 30, 2025 was $1,770, compared to $0 and $20,211 for the three and nine months ended September 30, 2024. The change in interest income is a result of the balance of the underlying interesting earning assets.

Interest expense

Interest expense for the three and nine months ended September 30, 2025 was $0.7 million and $1.5 million, respectively, compared to $0.3 million and $1.0 million for the three and nine months ended September 30, 2024. The change in interest expense is a result of a the underlying debt instruments. For further information refer to debt footnotes.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.